What is AddLife AB (publ) (ADDLF)?

AddLife AB (publ) (ADDLF) is a stock in the Healthcare sector, Medical - Instruments & Supplies industry. View full analysis on Stocks360.

What is the current price of ADDLF?

The current price of ADDLF is $15.75. Prices are updated in real time on Stocks360.

What is ADDLF's price-to-earnings (PE) ratio?

ADDLF's trailing twelve-month PE ratio is 34.43, based on current price and earnings per share data available on Stocks360.

What is ADDLF's market capitalization?

ADDLF's market capitalization is $1,847,337,424.00, placing it in the small-cap tier.

Does ADDLF pay a dividend?

Yes. ADDLF has a trailing twelve-month dividend yield of 0.01%. Dividend data is sourced from financial market providers and displayed on Stocks360.

AddLife AB (publ) (ADDLF)

Stock analysis · OTC · Healthcare · Medical - Instruments & Supplies

$15.75

Market Cap

$1.85B

PE (TTM)

34.43

EPS (TTM)

N/A

Dividend Yield

0.83%

Beta

1.41

Day Range

$7.94 – $42.00

52-wk Range

$7.94 – $42.00

Avg Volume

N/A

Volume

3.00K

AddLife AB (publ) (ADDLF) is a publicly traded company in the Healthcare sector. Latest price: $15.75. Market cap $1.85B. Trailing PE 34.43. Dividend yield 0.83%. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

1-Year Price

2025-10-30 · $42.00 2026-10-26 · $15.75 (-62.50%)

Earnings

Most Recent

Oct 21, 2026

EPS $0.10 vs est. $0.09

Beat by $0.02

Next Earnings

Feb 3, 2027

EPS estimate $0.14

Proprietary Signals

Signal snapshot temporarily unavailable.

About AddLife AB (publ)

AddLife AB (publ) is a prominent supplier of specialized equipment, medical devices, and reagents. The company primarily caters to healthcare systems, research organizations, and academic institutions, while also serving the food and pharmaceutical industries. Its operations are structured into two distinct segments: Labtech and Medtech. The Labtech segment delivers products, complete solutions, and services crucial for diagnostics, biomedical research, and laboratory work. This includes offerings across a broad spectrum such as haematology, pathology, point-of-care diagnostics, cell biology, genetics, microbiology, virology, molecular biology, clinical chemistry, and immunology, alongside consumables and analytical instruments. Additionally, this division provides essential support, maintenance, advisory, and training services. Conversely, the Medtech segment offers medical devices designed for diverse applications, including surgery, respiratory support, intensive care, wound treatment, enteral nutrition, fall prevention, and welfare technology. This also extends to assistive devices for ear, nose, and throat care, as well as bathroom aids and equipment tailored for children wit…

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	34.43×
P/S (TTM)	1.99×
P/B	3.71×
PEG	0.55×
P/FCF (TTM)	18.86×
EV / EBITDA	15.75×
EV / Sales	2.42×
Earnings Yield	2.92%
Free Cash Flow Yield	5.30%
Dividend Yield	0.83%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$25.90B
Revenue (TTM)	$10.70B
Net Income (TTM)	$619.83M
Free Cash Flow (TTM)	$1.21B
Net Debt	$4.66B
Working Capital	-$2.36B
Gross Margin	38.67%
Operating Margin	7.77%
Net Margin	6.02%
Return on Equity	11.32%
Return on Invested Capital	5.19%